MyHealth

Manage your account, request prescriptions, set up appointments & more.

LOG IN
Don't have an account
Contact Us
    • see more mega-menu-label
309_Cornerstone_cancer

OHSU Knight-Legacy Health Cancer Collaborative

The OHSU Knight-Legacy Health Cancer Collaborative is an integrated community cancer program for adults, encompassing radiation oncology, medical oncology and infusion services. Benefits for our patients include:

  • Treatment provided in multiple places, which often means staying closer to home for care
  • Legacy Cancer Institute and OHSU Knight physicians working together to coordinate cancer treatment
  • Access to a large number of cutting-edge clinical trials, through both cancer institutes
  • Personalized cancer medicine including access to OHSU Knight Cancer Institute's specialized diagnostic tests and Legacy's specialized pathology and research

OHSU Knight-Legacy Health Cancer Collaborative providers

Our team of cancer specialists work closely together on cancer treatment plans.

Locations

The OHSU Knight-Legacy Health Cancer Collaborative provides the most advanced cancer care throughout the community at the following locations: 

Portland
Legacy Emanuel Medical Center, North Portland
Infusion

Legacy Good Samaritan Medical Center, NW Portland
Medical Oncology, Infusion
Radiation Oncology

OHSU Knight Cancer Institute Radiation Medicine, SW Portland
Radiation Oncology

Westside
OHSU Knight Cancer Institute Beaverton
Medical Oncology, Infusion  
Radiation Oncology

Legacy Meridian Park Medical Center, Tualatin
Medical Oncology, Infusion

Eastside
Legacy Mount Hood Medical Center, Gresham
Medical Oncology, Infusion
Radiation Oncology

Vancouver
Legacy Cancer Institute-The Vancouver Clinic Building (on 87th Ave.)
Medical Oncology

Legacy Salmon Creek Medical Center, Vancouver
Infusion
Radiation Oncology

“Through the OHSU Knight-Legacy Health Cancer Collaborative, Legacy and OHSU patients have access to the highest level of community cancer care in conjunction with the latest in technology and research.”

- Nathalie Johnson, MD, FACS, Legacy Cancer Institute medical director and surgical oncologist